China Biotech Services Holdings Limited (HKG:8037)
Hong Kong · Delayed Price · Currency is HKD 0.5900
-0.0100 (-1.67%)
Jun 1, 2026, 1:26 PM HKT
HKG:8037 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -68.78 | -198.15 | -95.45 | 258.09 | 19.39 |
Depreciation & Amortization | 16.41 | 21.42 | 55.58 | 66.4 | 68.11 |
Other Amortization | 0.03 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | 0.11 | -0.3 | -2.78 | - |
Asset Writedown & Restructuring Costs | 6.74 | 84.57 | 21.19 | 1.72 | 0.19 |
Loss (Gain) From Sale of Investments | - | - | - | -2.71 | -0.49 |
Loss (Gain) on Equity Investments | - | - | 7.68 | 4.18 | - |
Stock-Based Compensation | - | 0.3 | 1.89 | 2.02 | 5.25 |
Provision & Write-off of Bad Debts | -0.03 | 0.68 | -1.14 | 3.9 | 0.52 |
Other Operating Activities | 9.8 | -9.9 | -295.23 | 587.43 | 173.34 |
Change in Accounts Receivable | -5.42 | -33.74 | 724.98 | -664.23 | -64.92 |
Change in Inventory | -33.08 | 0.21 | -2.22 | -13.99 | -2.41 |
Change in Accounts Payable | 28.36 | -17.4 | -232.89 | 237.1 | -158.27 |
Change in Other Net Operating Assets | - | - | 1.44 | 7.81 | 0.07 |
Operating Cash Flow | -45.98 | -151.89 | 191.72 | 482.75 | 40.51 |
Operating Cash Flow Growth | - | - | -60.28% | 1091.82% | -90.40% |
Capital Expenditures | -142.11 | -51.65 | -59.41 | -108.17 | -12.22 |
Sale of Property, Plant & Equipment | - | 0.04 | 0.37 | 0.03 | - |
Divestitures | - | - | -0.04 | 5.37 | - |
Sale (Purchase) of Intangibles | -3.35 | - | - | - | - |
Investment in Securities | - | 3.38 | 7.14 | -11.8 | 4.08 |
Other Investing Activities | 0.01 | 0.46 | -2.49 | -141.75 | 0.01 |
Investing Cash Flow | -145.45 | -47.77 | -54.43 | -256.31 | -8.12 |
Short-Term Debt Issued | - | - | 31.05 | 4.08 | 22.3 |
Long-Term Debt Issued | 244.46 | 103.58 | - | 38.98 | - |
Total Debt Issued | 244.46 | 103.58 | 31.05 | 43.05 | 22.3 |
Short-Term Debt Repaid | - | - | - | -8.15 | -12.05 |
Long-Term Debt Repaid | -64.56 | -35.92 | -11.2 | -10.53 | -53.74 |
Total Debt Repaid | -64.56 | -35.92 | -11.2 | -18.68 | -65.8 |
Net Debt Issued (Repaid) | 179.91 | 67.66 | 19.86 | 24.37 | -43.5 |
Issuance of Common Stock | - | 4.74 | - | - | - |
Repurchase of Common Stock | - | - | -3.64 | -2.99 | -4.31 |
Common Dividends Paid | - | - | -9.63 | - | - |
Other Financing Activities | 4.92 | 75.4 | -162.39 | -303.34 | -218.8 |
Financing Cash Flow | 184.83 | 147.81 | -155.8 | -281.96 | -266.61 |
Foreign Exchange Rate Adjustments | -0.23 | -1.32 | -2.18 | -2.26 | 0.25 |
Net Cash Flow | -6.83 | -53.17 | -20.68 | -57.78 | -233.99 |
Free Cash Flow | -188.09 | -203.54 | 132.31 | 374.58 | 28.29 |
Free Cash Flow Growth | - | - | -64.68% | 1224.12% | -90.42% |
Free Cash Flow Margin | -255.89% | -288.67% | 62.41% | 20.23% | 4.54% |
Free Cash Flow Per Share | -0.19 | -0.21 | 0.14 | 0.39 | 0.03 |
Cash Interest Paid | 8.52 | 5.87 | 6.39 | 3.83 | 3.29 |
Cash Income Tax Paid | 0.03 | -1.4 | 243.46 | 1.84 | -0.06 |
Levered Free Cash Flow | -160.38 | 10.45 | 57.36 | 186.61 | 25.28 |
Unlevered Free Cash Flow | -148.21 | 21.02 | 60.68 | 188.8 | 29.37 |
Change in Working Capital | -10.15 | -50.93 | 491.3 | -433.31 | -225.53 |